🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🌟 Big thanks to all national scientific, HPR, and PARE societies for joining us in the EULAR Manifesto project! 🙏 Exciting news: we have crafted a handy toolkit to support your campaigns around the Manifesto. Watch here👉pulse.ly/sgw6ylmzfl #euRMDplan #EULAR #Rheumatology

🌟We would like to extend our heartfelt gratitude to the esteemed MEPs who have endorsed the EULAR Manifesto. 🌏Your unwavering support signifies a shared dedication to advancing rheumatology in Europe. José Gusmão Miriam M. Lexmann Robert Biedroń #Biejat2025 Petri Sarvamaa #eularADVOCACY

✨ Looking forward to sharing our work on #psychosocial determinants of health in #RA today at #EULAR2024! 📍POS0309 #PARE Poster Tour IV 📅 TODAY 12:00 Dr. John Cush Elena Nikiphorou Dr Nkasi Stoll

A showcase of your Talents Beyond Science! About to start at the Science Cafe! #EULAR2024 Elena Nikiphorou

What psychosocial factors drive treatment outcomes and disease activity for people living with rheumatoid arthritis? #EULAR2024 POS0309-PARE Mrinalini Dey Elena Nikiphorou Dr. John Cush

Final session of the congress, focusing on self-management, incl the #EULAR guidelines. Elena Nikiphorou starts by discussing the relevance of #D2T RA in the context of self-management Dr. John Cush #EULAR2024

Thank you Elena Nikiphorou for reminding everyone that we should be supporting people holistically, not ‘just treating RMDs #EULAR2024

Delighted to announce that as of 1st Aug, I'll be promoted to Professor of Medical Statistics! 🎉 Huge thanks to all the wonderful people I've worked with and have put up with me over the years. Academia is a team sport and I couldn't have done it without you 🙏

🚨 Our work on social and clinical factors & #RA is out now RMD Open 📈 Significant associations with persistently active RA include: 🏠 Social deprivation 🎂 Younger age 👩🏻 Female gender 🚬 Smoking 😔 Depression 🔗 Link to paper: rmdopen.bmj.com/content/10/3/e… Elena Nikiphorou

What is the risk of HBV reactivation with the newer b-ts-DMARDs. Read more in this SLR/meta-analysis: academic.oup.com/rheumatology/a… Rheumatology & Rheumatology Advances in Practice

🚀Join us for an insightful webinar hosted by #EULAR and The Global Alliance for Musculoskeletal Health! 🗓️Thursday, 31 October 2024, 13:00 -14:00 CET Register now to learn how to build a healthier and safer digital workplace! 👉pulse.ly/8f0rjefzjh G-MUSC

To mark #WorldArthritisDay Alex Agius Saliba & Miriam M. Lexmann are hosting the Relaunch of the #EP Interest Group on RMDs, which affect 120 mln patients. RMDs are a major threat to health & productivity. We need #euRMDplan to cut the burden of RMDs on citizens & the economy. Join us!

Go Souzi Makri!! 🥳 Such important advocating!

It's #Arthritis Awareness Month and we should all talk more about #personalizedmedicine in #RA. Meet our patient research partner Jef van Rompay in a conversation with #BioTest trial leading member Felice Rivellese, from Experimental Medicine & Rheumatology.

Διατροφή για άτομα με ρευματοειδή αρθρίτιδα youtu.be/YoUD97UcoRw

Together with Elena Nikiphorou , consultant rheumatologist at King's College London, we had the chance to contribute to this Medscape article on the Guide to Supplements for Rheumatologic Diseases. medscape.com/viewarticle/gu…

Thanks to everyone who came to my poster on #HealthLiteracy & outcomes in #InflammatoryArthritis at #ACR24 Great to connect with rheumatologists, researchers & patients from around the world working on #SocialDeterminantsOfHealth Full abstract is here: acrabstracts.org/abstract/healt…

Ever heard of #genomics? It’s the study of all our DNA. By understanding the story of genomics we can unlock a world of possibilities for global health care.

Patients with idiopathic inflammatory #myopathies have higher burden of comorbidities that influence physical & mental health ▶️Age ▶️Active disease ▶️Basic multimorbidity ▶️#MentalHealth disorders 👉🏽academic.oup.com/rheumatology/a… by marco fornaro Latika et al Rheumatology & Rheumatology Advances in Practice

Select GCA Trial of Upadacitinib already published in NEJM nejm.org/doi/full/10.10…